The rate of complete response was significantly higher in the group that received CHOP + Rituximab than in the group that received CHOP alone (85% vs 65% respectively).
Tỷ lệ đáp ứng hoàn toàn ở nhóm CHOP + Rituximab cao hơn hẳn so với nhóm CHOP đơn thuần (85% so với 65% tương ứng).